high cholesterol

Join us for a special webcast: “Rethinking Cholesterol”

Gregory Curfman, MD

Assistant Professor of Medicine

Former Editor-in-Chief, Harvard Health Publishing

If the latest information on health and wellness is important to you, you will not want to miss a special live-streamed webcast, “Rethinking Cholesterol,” which will be aired on Thursday, September 24, from 12:30pm to 1:30pm Eastern time. The webcast, which is free to all viewers, is co-sponsored by Reuters, Harvard Health Publishing, the Harvard T.H. Chan School of Public Health, and Harvard Medical School.

Studies support broader use of cholesterol-lowering statins

The latest guidelines used to determine who should take a cholesterol-lowering statin to prevent heart disease appear to be more accurate and cost-efficient than the previous guidelines. That’s according to two studies led by Harvard researchers, both published in this week’s Journal of the American Medical Association. The new guidelines, published in 2013 by the American College of Cardiology and the American Heart Association, recommend a statin for men and women between the ages of 40 and 75 who have a 7.5% or higher risk of having a heart attack or stroke over the next 10 years. The JAMA studies show that the new guidelines provide a more accurate assessment of who would benefit from a statin and who wouldn’t, and are more cost-effective than the older guidelines. Statins aren’t a cure-all. Eating a healthier diet, exercising often, and not smoking will go a long way to preventing heart attack and stroke.